Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for WAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 2.00M
March 31, 2026 95.00M
December 31, 2025 -42.13M
September 30, 2025 -25.52M
June 30, 2025 -58.35M
March 31, 2025 -26.25M
December 31, 2024 -52.11M
September 30, 2024 -26.05M
June 30, 2024 -36.12M
March 31, 2024 -29.74M
December 31, 2023 -37.94M
September 30, 2023 -37.40M
June 30, 2023 -1.333B
March 31, 2023 -34.41M
December 31, 2022 -62.18M
September 30, 2022 -38.38M
June 30, 2022 -26.40M
March 31, 2022 18.99M
December 31, 2021 16.80M
September 30, 2021 32.68M
June 30, 2021 -122.10M
March 31, 2021 -159.00M
December 31, 2020 -37.53M
September 30, 2020 -34.23M
June 30, 2020 -62.16M
Date Value
March 31, 2020 -130.18M
December 31, 2019 -56.64M
September 30, 2019 40.38M
June 30, 2019 351.02M
March 31, 2019 434.04M
December 31, 2018 425.58M
September 30, 2018 51.34M
June 30, 2018 310.54M
March 31, 2018 895.84M
December 31, 2017 -131.76M
September 30, 2017 -110.14M
June 30, 2017 -196.80M
March 31, 2017 -97.05M
December 31, 2016 -49.24M
September 30, 2016 -171.00M
June 30, 2016 -69.85M
March 31, 2016 -197.82M
December 31, 2015 -105.23M
September 30, 2015 -30.00M
June 30, 2015 -208.06M
March 31, 2015 -56.45M
December 31, 2014 -79.61M
September 30, 2014 -148.66M
June 30, 2014 -53.81M
March 31, 2014 -119.95M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. -1.032B
Thermo Fisher Scientific, Inc. 164.00M
Danaher Corp. -10.15B
Revvity, Inc. -3.505M
Illumina, Inc. -122.00M